FDA Approves World's First Long-Term Implantable Continuous Glucose Monitoring System for Marketing in United States

Go back to FDA Approves World's First Long-Term Implantable Continuous Glucose Monitoring System for Marketing in United States

Senseonics Holdings (SENS) Resumes Trading

June 21, 2018 3:36 PM EDT

Senseonics Holdings (NYSE: SENS) Resumes Trading

... More